Trial Profile

Clinical study for psilocybin oral thin film strip

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 20 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Psilocybin (Primary)
Indications Neurological disorders; Substance-related disorders
Focus Adverse reactions; First in man

Most Recent Events

16 Sep 2022 According to a Revive Therapeutics media release, company expects to conduct this clinical study in 2023.
24 Jan 2022 New trial record
17 Jan 2022 According to a Revive Therapeutics media release, the company expect to initiate this study in Q4-2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com